Comparison of Intralipid With SMOF Lipid Following HSCT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The goal of this clinical trial is to have a successful engraftment in after bone transplantation. Acute leukemia patient of both sexes aged 2 to 18 years, who are transplant candidates, participate in this study. Primary hypothesis is Patients receiving SMOF LIPID will have better grafts than patients receiving intralipid. Also, complications after surgery and malnutrition will be less in this group.
Epistemonikos ID: 16a6dbd6115d5fc149fe8110ad71ad628ab80203
First added on: Nov 01, 2024